| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.02B | 10.14B | 9.96B | 9.68B | 13.24B |
| Gross Profit | 5.68B | 5.48B | 5.23B | 5.33B | 5.87B |
| EBITDA | 1.55B | 1.35B | 1.31B | 1.46B | 2.14B |
| Net Income | 725.81M | 401.91M | 82.32M | 391.70M | 984.30M |
Balance Sheet | |||||
| Total Assets | 14.46B | 13.95B | 13.76B | 13.51B | 12.78B |
| Cash, Cash Equivalents and Short-Term Investments | 6.11B | 6.97B | 6.58B | 6.35B | 5.52B |
| Total Debt | 12.35M | 10.10M | 13.08M | 12.59M | 23.98M |
| Total Liabilities | 6.60B | 6.53B | 6.47B | 6.02B | 6.75B |
| Stockholders Equity | 7.86B | 7.42B | 7.29B | 7.49B | 6.03B |
Cash Flow | |||||
| Free Cash Flow | 1.44B | 633.70M | 552.04M | -290.52M | 1.79B |
| Operating Cash Flow | 1.74B | 1.19B | 1.34B | 515.07M | 2.43B |
| Investing Cash Flow | -2.15B | -523.03M | -2.01B | -2.21B | -653.23M |
| Financing Cash Flow | -287.80M | -286.14M | -285.94M | 1.12B | -178.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥8.81B | 10.35 | ― | 1.24% | 11.42% | 29.26% | |
79 Outperform | ¥15.08B | 9.76 | ― | 2.60% | 16.35% | 57.53% | |
71 Outperform | ¥8.12B | 10.22 | ― | 3.62% | -0.94% | 51.68% | |
68 Neutral | ¥13.91B | 21.67 | ― | 2.19% | 14.43% | 10.99% | |
64 Neutral | ¥11.51B | 13.51 | ― | 0.91% | 15.68% | -64.57% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
43 Neutral | ¥4.67B | -9.90 | ― | ― | 49.01% | -21.56% |